Exploring hsa_circ_0100833 as a Potential Biomarker in Oral Squamous Cell Carcinoma: Bioinformatics and Experimental Insights
Clinical and Experimental Dental Research · 2026
DOI: 10.1002/cre2.70399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dental Research, 2026. Verfasst von Behnaz Raei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, NT.C., Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Mouth Neoplasms, Biomarkers, Tumor, RNA, Circular, Carcinoma, Squamous Cell. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with few reliable early diagnostic markers. Bioinformatic screening identified hsa_circ_0100833 as a differentially expressed circRNA in OSCC. Its potential significance in OSCC was then examined experimentally. Material and Methods Differential circRNA expression was profiled using the GSE145608 dataset and Limma software. ROC curve analysis, circRNA–miRNA–mRNA interaction prediction, functional enrichment, and survival analysis were then used. Hsa_circ_0100833 expression was measured by qRT‐PCR in 20 paired OSCC and adjacent normal tissues. This analysis was also performed in CAL‐27 and FaDu cell lines ( n = 3 each) and three normal human gingival fibroblast cultures. hsa‐miR‐607 and SORBS1 were quantified in parallel.
Results
Differential expression analysis of the GSE145608 dataset identified hsa_circ_0100833 as down‐regulated in OSCC. Bioinformatic analysis then predicted a binding interaction between this circRNA and hsa‐miR‐607. Hsa_circ_0100833 was significantly reduced in OSCC tissues and cell lines relative to normal controls; hsa‐miR‐607 was up‐regulated, and SORBS1 showed parallel downregulation. ROC analysis revealed AUC values of 0.799 in cell lines and 0.712 in tissue samples. The predicted ceRNA network was enriched for PI3K‐Akt signaling and focal adhesion pathways. Conclusion hsa_circ_0100833 was down‐regulated in OSCC and may act as a tumor suppressor through a hsa‐miR‐607/SORBS1‐dependent mechanism. Its diagnostic potential warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, NT.C., Islamic Azad University, Tehran, Iran.
- Department of Genetics, TeMs.C., Islamic Azad University, Tehran, Iran.
- Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital, Faculty of Medicine, TeMs.C., Islamic Azad University, Tehran, Iran.
- Endocrine Research Center, The Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
- Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mehrdad Hashemi, Mojgan Alaeddini
Zitieren
APA
Raei, B., Seyedena, Y., Hashemi, M., Hosseinkhan, N., & Alaeddini, M. (2026). Exploring hsa_circ_0100833 as a Potential Biomarker in Oral Squamous Cell Carcinoma: Bioinformatics and Experimental Insights. Clinical and Experimental Dental Research. https://doi.org/10.1002/cre2.70399
Vancouver
Raei B, Seyedena Y, Hashemi M, Hosseinkhan N, Alaeddini M. Exploring hsa_circ_0100833 as a Potential Biomarker in Oral Squamous Cell Carcinoma: Bioinformatics and Experimental Insights. Clinical and Experimental Dental Research. 2026. doi:10.1002/cre2.70399
BibTeX
@article{Raei2026,
author = {Raei, Behnaz and Seyedena, Yousef and Hashemi, Mehrdad and Hosseinkhan, Nazanin and Alaeddini, Mojgan},
title = {Exploring hsa_circ_0100833 as a Potential Biomarker in Oral Squamous Cell Carcinoma: Bioinformatics and Experimental Insights},
journal = {Clinical and Experimental Dental Research},
year = {2026},
doi = {10.1002/cre2.70399}
}
EUVIMED